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Abstract Glutathione and thioredoxin are complementary
antioxidants in the protection of mammalian tissues against
oxidative–nitrosative stress (ONS), and ONS is a principal
cause of symptoms of hepatic encephalopathy (HE) associ-
ated with acute liver failure (ALF). We compared the
activities of the thioredoxin system components: thioredoxin
(Trx), thioredoxin reductase (TrxR) and the expression of the
thioredoxin-interacting protein, and of the key glutathione
metabolizing enzyme, glutathione peroxidase (GPx) in the
cerebral cortex of rats with ALF induced by thioacetamide
(TAA). ALF increased the Trx and TrxR activity without
affecting Trip protein expression, but decreased GPx activity
in the brains of TAA-treated rats. The total antioxidant
capacity (TAC) of the brain was increased by ALF sug-
gesting that upregulation of the thioredoxin may act towards
compensating impaired protection by the glutathione sys-
tem. Intraperitoneal administration of L-histidine (His), an
amino acid that was earlier reported to prevent acute liver
failure-induced mitochondrial impairment and brain edema,
abrogated most of the acute liver failure-induced changes of
both antioxidant systems, and significantly increased TAC of
both the control and ALF-affected brain. These observations
provide further support for the concept of that His has a
potential to serve as a therapeutic antioxidant in HE. Most of
the enzyme activity changes evoked by His or ALF were not
well correlated with alterations in their expression at the
mRNA level, suggesting complex translational or post-
translational mechanisms of their modulation, which deserve
further investigations.
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Introduction
Acute liver failure (ALF) causes a spectrum of pathogenic
events in the brain culminating in astrocytic swelling and
brain edema, whereby accumulation of high concentrations
of ammonium ions (ammonia) in blood and brain appear to
be the main causative factor [1–4]. Evidence from different
studies suggest that oxidative/nitrosative stress (ONS)
plays a key role in the pathogenesis of hepatic encepha-
lopathy (HE) associated with ALF. Increased manifesta-
tions of events related to ONS, e.g.: superoxide
accumulation, lipid peroxidation, protein nitration and
nitrosylation, nucleic acid oxidation, and changes in anti-
oxidant systems were found in the brains of ALF in
patients and animals, and in in vitro models ([5–9], recently
reviewed in [10]).
Glutathione (GSH), the most abundant low molecular
antioxidant in brain has been shown to be involved in the
response to ALF, but the evidence has not been unambigu-
ously conclusive. In vitro studies revealed that ammonia
leads to a decrease of GSH content in cultured neurons [11]
but to an increase in cultured astrocytes [12, 13], which was
associated with increased uptake of its precursor amino acid,
cystine [13]. In the in vivo setting, thioacetamide (TAA)-
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induced ALF or simple acute hyperammonemia (HA)
resulted in increased extracellular GSH accumulation and
degradation in rat brain [14]. On the other hand, a significant
decrease was observed in the brain mitochondria during ALF
in rats [15]. Depending on the HA or ALF model employed,
the brain activity of the key GSH-metabolizing enzyme,
glutathione peroxidase (GPx) was noted to either go up [16]
or down [17, 18].
In addition to the GSH system, the antioxidative respon-
ses of mammalian tissues, including the brain, engage one
other thiol-reducing system, the thioredoxin (Trx) system
[19–22]. Thioredoxins (Trxs) reduce disulfides in proteins
and their regeneration takes place through thiol reduction by
the flavo- and selenoprotein–thioredoxin reductase (TrxR)
with NADPH. Mammalian tissues express two main Trx
systems, the cytosolic couple: Trx1/TrxR1 and the mito-
chondrial couple: Trx2/TrxR2. The activity of the Trx sys-
tem is also controlled by an endogenous factor, thioredoxin-
interacting protein (Trxip) [23, 24]. All the components of
the Trx system are known to be present in the central nervous
system (CNS) tissues (references in [21, 22]). By analogy to
GSH [12–14], it may be speculated that Trx is likewise an
astroglia-derived neuroprotectant. TrxR and GSH-metabo-
lizing GPx are selenium (Se)-containing antioxidants. There
is a high priority for Se supply in the brain and even minimal
alteration of Se-containing enzymes activity is correlated
with neurodegenerative diseases associated with ONS, such
as Alzheimer’s (AD) or Parkinson’s disease (references in
[19, 21, 22]). While selenoprotein alterations in HE-affected
brain have not been directly studied, changes in Se-trans-
porting proteins have been reported in blood of HE patients
[25]. Bearing in mind the above data, in the present study we
investigated whether ALF induces changes in Se-dependent
Trx/TrxR system and GPx activity, and what is the relation
between the two systems in the response to ALF.
L-histidine (His) counteracts brain edema in ALF [26]
by a mechanism involving reduction of ammonia-induced
mitochondrial permeability transition and astrocytic
swelling in vitro [27], and correction of GSH imbalance in
ALF-affected brain [15]. It thus appeared of interest to see
whether and in what degree His would interfere with the
effects of ALF on GPx and Trx system. Finally, to evaluate
the effectiveness of the sum of responses of the two sys-
tems to ALF and/or His, we measured the total antioxidant
capacity of the tissue under these conditions.
Experimental Procedure
ALF Model
ALF was induced in adult male Sprague–Dawley rats
(220–280 g) by three intraperitoneal (i.p.) injections of
thioacetamide (TAA), 300 mg/kg body weight, at 24 h
intervals [28]. Typical symptoms of acute HE are observed
in this model, including elevated blood and brain ammonia
levels and brain edema associated with increased brain Gln,
the magnitude of the changes resembling severe stages of
HE in humans ([26, 28], and references therein). His at a
dose of 100 mg/kg was injected i.p. 2 h before each TAA
injection; His injection does not affect ammonia level in
the brain [26]. Controls received equivalent volume of
saline. Animals were sacrificed 24 h after the last admin-
istration. Tissue from brain cortex was homogenized in a
buffer appropriate to each protocol or frozen at -80 C.
GPx Activity
GPx activity was measured as previously described in [12],
the procedure being based on the original method of [29],
with minor modifications. Fresh tissue was homogenized
(1/8; w/v) in a buffer: 50 mM Tris (pH 7.6), 0.25 mM
EDTA, 0.5 mM DTT, centrifuged (10,0009g, 5 min, 4 C)
and supernatant was used to analyze enzyme activity and
protein level. The reaction mixture: 100 mM Tris (pH 7.6),
0.5 mM EDTA, 1 mM DTT, 1 mM GSH, 0.2 mM
NADPH and 0.4 unit/ml glutathione reductase was added
to approx. 40 lg of protein extract. Addition of 0.2 mM
tert-butyl hydroperoxide (TBHP) (final volume 0.2 ml)
initiated the reaction and the change in absorbency of
NADPH (extinction coefficient 6.22 mM-1 cm-1) was
measured at 340 nm for 5 min, at 0.5 min interval, at
25 C. Simultaneously a nonspecific reduction of NADPH
was determined in each probe without TBHP. The results
are presented as nmol/(min mg of protein).
TrxR Activity
TrxR activity was measured using a Thioredoxin Reduc-
tase Assay Kit (Sigma Aldrich) according to the manu-
facturer’s protocol for 96 well plate assay. Tissue was
homogenized (1/4; w/v), centrifuged (10,0009g, 5 min,
4 C) and supernatant was used for analysis of enzyme
activity and protein level. Approx. 100 lg of protein
extract was used in a reaction mixture, addition of 5,50-
dithiobis-(2-nitrobenzoic acid) (DTNB) solution initiated
the reaction and the change in absorbency caused by
2-nitro-5-thiobenzoic acid (TNB; extinction coefficient
14.15 mM-1 cm-1) production was measured at 415 nm
for 2 min, at 10 s interval (at 25 C). The results are pre-
sented as nmol/(min mg of protein).
Trx Activity
Trx was determined according to the method of [30]. Fresh
tissue was homogenized (1/8; w/v) in a buffer: 50 mM Tris
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(pH 7.6), 5 mM EDTA and protease inhibitor cocktail,
centrifuged (10,0009g, 5 min, 4 C) and supernatant was
used for analysis of enzyme activity and protein level.
Samples (approx. 40 lg of protein) were incubated 20 min
in 37 C in a reaction mixture: 85 mM HEPES (pH 7.6),
2.5 mM EDTA, 0.3 mM insulin, 0.72 mM NADPH with or
without 100 nM TrxR to determine non-specific reduction
of insulin (final volume 0.1 ml). Insulin reduced through
Trx system reacts afterwards with 1 mM DTNB (in 6 M
guanidine hydrochloride, pH 8.0) added at the end of
incubation (final volume 0.3 ml). Absorbance was mea-
sured at 415 nm and the results were calculated using
extinction coefficient for the product of the reaction—TNB
in guanidine hydrochloride (13.6 mM-1 cm-1), and pre-
sented as nmol/mg of protein [31].
TrxR1 and Trxip Assay
TrxR1 and Trxip protein level were determined by
enzyme-linked immunosorbent assay (ELISA) Kits (My-
BioSource; catalog nos. MBS881784 and MBS261228).
Tissue was homogenized and centrifuged, and supernatant
was used for ELISA according to the manufacturer’s pro-
tocol. The results are presented as ng/mg of protein.
Total Antioxidant Capacity
Total antioxidant capacity (TAC) was determined using an
Antioxidant Assay Kit (Sigma–Aldrich, catalog no.
CS0790). Fresh tissue was homogenized (1/5; w/v) in
Assay Buffer, centrifuged (12,0009g, 15 min, 4 C) and
supernatant was used to analysis of TAC and protein level.
Approx. 30 lg of protein extract was used in reaction
mixture, which contained myoglobin and 2,20-azino-bis(3-
ethylbenzthiazoline-6-sulfonic acid) (ABTS). Addition of
hydrogen peroxide produces ferryl myoglobin radical
which oxidizes ABTS to a chromogen detected spectro-
photometrically at 415 nm. TroloxTM curve was used as a
standard for antioxidants’ concentration and results were
calculated as nmol TroloxTM/mg of protein.
Protein Determination
The results of enzymes activity and ELISA assay were
calculated on protein content, determined using BCA
Protein Assay Kit (Pierce) according to manufacturer’s
protocol.
Quantitative Real Time PCR (qRT-PCR)
Total RNA was isolated from frozen rat cortex using the
standard protocol for Tri reagent [32]. To remove genomic
DNA, a Recombinant DNase I (rDNase I) (Ambion) was used
according to the method described by a producer. Comple-
ment DNA was synthesized from 1 lg of RNA with Reverse
Transcription Kit (Applied Biosystems). The level of gene
expression was measured with a real-time PCR System using
TaqMan Gene Expression Assay (Applied Biosystems) with
1 ll cDNA in 10 ll of reaction volume. The assay IDs were:
Rn00587437_m1 (Txn1, Trx1), Rn00584162_g1 (Txn2,
Trx2), Rn01503798_m1 (Txnrd1, TrxR1), Rn00574868
(Txnrd2, TrxR2), Rn00577994_g1 (Gpx1, Gpx1),
Rn01533891_g1 (Txnip, Trxip), Rn00667869_m1 (bActin,
b-actin—internal control). Change in gene expression was
determined by the 2-DDCt method [33] and expressed as rel-
ative change to control level.
Statistical Analysis
The results were expressed as mean ± SD. Differences
among experimental groups were evaluated by a one-way
ANOVA analysis of variance with post hoc Tukey’s test.
P \ 0.05 was considered statistically significant.
Results
ALF decreased by 23 % the GPx activity (Fig. 1a) but
increased by 66 % the TrxR activity (Fig. 2a), and by 65 %
the Trx-reducing activity (Fig. 3a). Administration of His
abrogated all the enzyme activity changes evoked by ALF
(Figs. 1a, 2a, 3a). His added alone significantly increased
the activities of TrxR or GPx, and tended to increase the
Trx activity, albeit the increase did not reach statistical
significance.
Increase of the GPx activity in the ALF animals treated
or not treated with His correlated positively with the
Fig. 1 Effect of ALF in the TAA model (TAA) or/and histidine (His)
administration on glutathione peroxidase (GPx) activity (a, n = 6)
and glutathione peroxidase 1 (GPx1) mRNA level (b, n = 7–8) in rat
brain cortex. Results are mean values ± SD. *p \ 0.05, **p \ 0.01,
***p \ 0.001 versus Control, ###p \ 0.001 versus TAA, $$$p \ 0.001
versus His
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increased mRNA level of GPx1 isoform. No such a cor-
relation occurred upon treatment with His alone, which
evoked a decrease of GPx1 mRNA (Fig. 1b). ALF
increased both TrxR1 mRNA level (Fig. 2b) and protein
expression (Fig. 2d), which was reflected by elevation of
TrxR activity (Fig. 2a). Co-administration of His abolished
the effects of ALF (Fig. 2a, b, d). TrxR2 mRNA level was
not changed after TAA treatment, but decreased after His
administration (Fig. 2c). The mRNA coding for the cyto-
solic isoform of Trx, Trx1 remained unchanged comparing
to control level (Fig. 3b), and the expression of mRNA
coding for the mitochondrial Trx isoform—Trx2, was
decreased marginally after TAA treatment (Fig. 3c). His
down-regulated the expression of both Trx isoforms. Taken
together, except for the coordinated response of TrxR at the
level of transcription, translation and activity to ALF, other
changes in the enzyme activities poorly correlated with the
expression of their mRNAs.
While ALF did not affect the expression of the thiore-
doxin-interacting protein (Trxip), the Trxip content was
increased significantly after His treatment, both in control
brains and brains derived from ALF rats (Fig. 4a). As was
the case with previous Trx system components, changes in
Trxip protein content did not correspond with Trxip mRNA
levels, which were increased in ALF rats treated or not
treated with His, but decreased upon His treatment alone
(Fig. 4b).
Both ALF and His treatment of control rats increased by
50 % the total antioxidant capacity (TAC) of rat brain
cortical homogenates, and an increase of identical magni-
tude was noted in ALF rats treated with His (Fig. 5).
Discussion
While the predominant role of the glutathione system in
antioxidant defense of the brain has been established
beyond doubt [34], relatively little is known about the
physiological significance of the thioredoxin system in this
capacity [20–22]. The present study is to our knowledge
Fig. 2 Effect of ALF in the TAA model (TAA) or/and histidine (His)
administration on thioredoxin reductase (TrxR) activity (a, n = 4–5),
thioredoxin reductase 1 (TrxR1) (b, n = 6), thioredoxin reductase 2
(TrxR2) (c, n = 6–7) mRNA level and TrxR1 protein level (d, n = 6)
in rat brain cortex. Results are mean values ± SD. *p \ 0.05,
**p \ 0.01, ***p \ 0.001 versus Control, #p \ 0.05, ##p \ 0.01,
###p \ 0.001 versus TAA
Fig. 3 Effect of ALF in the
TAA model (TAA) or/and
histidine (His) administration on
thioredoxin (Trx) activity (a,
n = 4–5), and the expression of
mRNAs coding Trx1 (b,
n = 7–8) and Trx2 (c, n = 7–8)
in rat brain cortex. Results are
mean values ± SD. *p \ 0.05,
**p \ 0.01, ***p \ 0.001
versus Control, #p \ 0.05,
###p \ 0.001 versus TAA
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the first in the literature to address the role of the Trx/TrxR
system relative to the GSH system, in the response of the
brain to ALF.
ONS evoked by different factors activates various
pathways leading to elevated antioxidant activity, which is
often considered to be adaptive [35]. Increase in total
glutathione content (GSx) in cultured astrocytes treated
with ammonia, which is a HE model in vitro, is interpreted
this way [12, 13]. However in the present ALF model, no
changes in GSx level, GSH/GSSG ratio or glutathione
reductase (GR) activity were observed in the cerebral
prefrontal cortex [15]. On the top of that, mitochondrial
GSH, which is considered to be a key factor in antioxidant
protection, and GPx activity showed a decrease in rat brain
cortex during ALF ([15] and Fig. 1a, respectively). This
result corresponds to the decrease of the GPx activity
previously found brain cortex of rats in the TAA model of
ALF similar to that employed in the present study [17], rats
with acute HA [18, 36], and in astrocytes treated with
ammonium ions [12]. The antioxidant function of GPx
mainly consists in reducing hydrogen peroxide through a
mechanism requiring GSH as a electron donor and GR with
NADPH for GSH regeneration. Decreased activity of GPx
might lead to reduced elimination of hydrogen peroxide
and, in consequence, increased presence of metabolites
evoking ONS [34]. Since down-regulation of GPx, next to
impaired mitochondrial GSH pool [15] is an Achilles’ heel
in GSH-dependent antioxidant system, the results suggest
that GSH may not be effective enough in coping with the
ONS evoked by ALF. By contrast, both TrxR (Fig. 2a) and
Trx (Fig. 3a) activities increased significantly in ALF rats.
We interpret the increased Trx/TrxR system activity as a
neuroprotective response to ONS in ALF. In this context,
upregulation of Trx/TrxR system activity in ALF might
compensate for the reduced efficiency of the GSH system,
and contribute to the increase of TAC in ALF rats.
The role of the effect of ALF on the thioredoxin system is
difficult to relate to the findings in other settings of brain
pathology, as the available evidence concerning the Trx/TrxR
response in different neurological disorders is ambiguous.
Upregulation of brain Trx was demonstrated in newborn rats
subjected to hyperoxia [37], and in adult mice in which brain
ischemia was induced by transient middle cerebral artery
occlusion [38]. In AD affected brain, TrxR activity was
reported to be increased, whereas Trx level was decreased
[39], rendering the overall picture inconclusive. Trx was also
found decreased in astrocytes treated with an oxidative stress-
inducing agent, t-butylhydroquinone [40]. On the other hand,
the observation of elevated Trx level in astrocytes during
ischemia [41], and its active release from an astroglia-derived
cell line exposed to hydrogen peroxide [42], would suggest its
potential role as an astroglia-derived neuroprotective factor.
To evaluate whether the enzyme activity changes
observed in ALF and/or His treated rats are related to gene
expression we analyzed the levels of mRNAs coding for
GPx1 and the major Trx and TrxR isoforms. Decreased
GPx1 mRNA level (Fig. 1b) is consistent with decreased
GPx activity (Fig. 1a) in brain cortex of rats with ALF. Out
of the eight different GPx isoforms present in mammalian
tissues [43] we concentrated on GPx1, the first selenopro-
tein identified [44]. Of note in this context, GPx1 is con-
sidered to be the most vulnerable to Se deficiency among
all selenoproteins—GPx1 mRNA decreases in Se defi-
ciency in different tissues [43, 45]. The hypothesis that Se
metabolism may be altered in HE was based on studies
Fig. 4 Effect of ALF in the TAA model (TAA) or/and histidine (His)
administration on thioredoxin-interacting protein (Trxip) protein (a,
n = 6–7) and mRNA level (b, n = 6–8) in rat brain cortex. Results
are mean values ± SD. *p \ 0.05, ***p \ 0.001 versus Control,
###p \ 0.001 versus TAA, $$$p \ 0.001 versus His
Fig. 5 Effect of ALF in the TAA model (TAA) or/and histidine (His)
administration on total antioxidant capacity in rat brain cortex.
Results are mean (n = 3–4) values ± SD. **p \ 0.01 versus Control
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demonstrating a decrease of Se and Se-transporting sele-
noprotein P level in plasma of patients with cirrhosis [25],
and an increase in mRNA level of two other selenoproteins
(SelV and SelS) in post mortem brains with HE [46]. The
results of the present study are generally consistent with the
above hypothesis. More detailed studies on Se metabolism
in ALF-affected brain appear warranted in this context.
Poor correlation between mRNA expression and
enzyme activities for Trx and TrxR indicates the primary
involvement of translational or posttranslational mecha-
nisms in the ALF-induced changes, perhaps compounded
by posttranscriptional modification of mRNA itself. Of
note, RNA oxidation [5] and protein nitration and phos-
phorylation are the phenomena reported to accompany
ONS induced in cultured astrocytes by ammonia [47].
Quite exceptionally, in the case of the TrxR1 isoform,
increased TrxR activity in ALF (Fig. 2a) correlated with
the increase of both the transcript level (Fig. 2b) and pro-
tein level (Fig. 2d).
To get more insight into the mechanism underlying Trx
activity regulation, we decided to study the fate of the
endogenous Trx inhibitor, thioredoxin-interacting protein
(Trxip). Trxip which exerts its inhibitory action by binding
to the active site of Trx [23], is thought to be vulnerable to
different pathophysiological changes, some of which are
also typical of HE. For instance, decreased glucose
metabolism decreases Trxip expression [24], whereas
accumulation of glutamine [48] or nitric oxide [49], or
N-methyl-D-aspartate receptor (NMDAR) activation are
known to up-regulate the expression of this protein [50].
The reasons why Trxip protein level was not affected by
ALF alone, and why this occurred despite elevation of
mRNA level is unclear. The discrepancies once again point
to the fact that ALF may differently effect expression of
one and the same factor at the transcriptional and transla-
tional level. Since Trx-Trxip binding might be disrupted as
a consequence of accumulation of reactive oxygen species
[23], we cannot exclude that even though Trxip protein
expression is unchanged by ALF, the accumulating reac-
tive oxygen species may impair its binding to Trx.
As outlined in the Introduction, His exerts beneficial
effects on the status of ALF-affected brain and of ammonia-
or glutamine-treated astrocytes in culture, by preventing
mitochondrial dysfunction and ONS [26, 27]. A previous
study from this laboratory demonstrated that His may render
antioxidant protection by restoring brain tissue GSH [15].
The present observations that: (1) His up-regulated GPx and
TrxR activity in control rats, and (2) abolished the ALF-
induced changes in the Trx/TrxR system and GPx activity,
further support the cytoprotective potential of this amino
acid in the setting of ALF. We think that in both cases an
effect of His could be a consequence of the improvement of
mitochondrial function which occurs by increasing mito-
chondrial GSH level [15] and of the interference with Gln
transport in astrocytes [27]. An alternative or additional
possibility stems from the direct antioxidative potential of
His, which includes reactive oxygen species scavenging or
prevention of ONS generation by metal binding [51]. Studies
on the effect of His on the reactive oxygen and nitrogen
species in different compartments of control- and ALF-
affected brain need to be carried out: such experiments are
under way in this laboratory. His also up-regulated Trxip
expression in both control and ALF rats as well, an obser-
vation that escapes simple interpretation. As was the case
with the responses to ALF, effects of His on mRNA and
protein levels are often opposite. These discrepant effects
could, for instance, be related to the potent interaction of His
with zinc ions [52]. Zinc is a critical regulator of activity for
numerous transcription factors [53, 54] and other proteins,
including TrxR [55]. ONS-related free zinc accumulation
was observed in cultured astrocytes treated with ammonia
[56]. Assuming that similar phenomena occur in ALF, His,
through interaction with free zinc could affect gene expres-
sion and/or activity of other antioxidants. The above men-
tioned effects of His may render adaptive up-regulation of
other antioxidant systems less critical.
The total antioxidant capacity (TAC) of the rat brain
cortex was increased in rats subjected to ALF, and to His in
both control and ALF rats (Fig. 5). The increase noted in
ALF rats bespeaks an autoprotective response against oxi-
dative stress. It is to be emphasized here that ALF and other
forms of HE are considered to be a reversible condition only
infrequently associated with astrocytic or neuronal death
[57]. With regard to the interplay between the two antioxi-
dative systems under study, the most simple interpretation is
that the decreased GSH system activity is effectively com-
pensated by the Trx system. Clearly, this attractive hypoth-
esis deserved further detailed investigations which must also
include simultaneous in-depth analysis of the fate of other
cellular antioxidants contributing to TAC. As to His, it
remains to be investigated by which of the multiple mecha-
nisms attributed to this amino acid underlies its TAC-
improving activity. Whatever the nature of its action, the
observed effect support earlier suggestions that His has a
potential to serve as a therapeutic modality in HE.
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